Skip to main content

Advertisement

Table 4 Survival of patients with breast cancer according to different stages and molecular subtypes

From: The influence of stage at diagnosis and molecular subtype on breast cancer patient survival: a hospital-based multi-center study

Characteristic 5-year OS rate [% (95% CI)] 5-year CSS rate [% (95% CI)]
Overall 89.4 (88.5–90.3) 90.3 (89.4–91.1)
Stage
 I 96.5 (95.4–97.4) 97.1 (96.1–97.9)
 II 91.6 (90.3–92.7) 92.6 (91.4–93.6)
 III 74.8 (71.0–78.2) 75.6 (71.8–78.9)
 IV 40.7 (31.0–50.1) 42.7 (32.8–52.1)
Molecular subtype
 Luminal A 92.6 (91.5–93.6) 93.2 (92.1–94.2)
 Luminal B 88.4 (85.3–90.9) 89.1 (86.1–91.5)
 HER2 83.6 (79.3–87.0) 85.4 (81.3–88.7)
 Triple-negative 82.9 (79.3–85.9) 83.5 (79.9–86.4)
  1. OS overall survival, CSS cancer-specific survival, CI confidence interval